Oramed Pharmaceuticals Inc. Soared
Mon, Dec 02, 2019 at 05:30 PM
Oramed Pharmaceuticals Inc. (ORMP:NASDAQ) shot up at $5.72, representing a gain of 29.7%. On Fri 29 Nov 19, ORMP:NASDAQ touched a New 2-Week High of $4.41. The stock appeared on our News Catalysts scanner on Mon 02 Dec 19 at 09:15 AM in the 'MISCELLANEOUS' category. From Fri 08 Nov 19, the stock recorded 50.00% Up Days and 60.00% Green Days
About Oramed Pharmaceuticals Inc. (ORMP:NASDAQ)
Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
Top 10 Gainers:
- Kodiak Sciences Inc. (KOD:NASDAQ), 72.47%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 56.33%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 44.22%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 41.09%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 36.13%
- Oramed Pharmaceuticals Inc. (ORMP:NASDAQ), 29.71%
- Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ), 29.33%
- NF Energy Saving Corporation (BIMI:NASDAQ), 28.9%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 28.57%
- Hexindai Inc. (HX:NASDAQ), 26.88%